UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.6% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3451
PUT
Union Pacific
UNP
$176B
| $9.9M | ﹤0.01% |
36,300
-160,100
| -82% | -$42M |
2014 Q4
46 quarters
|
|
3452
Seacoast Banking Corp of Florida
SBCF
$3.29B
| $9.9M | ﹤0.01% |
296,755
-81,968
| -22% | -$2.56M |
2014 Q4
46 quarters
|
|
3453
Invesco Municipal Opportunity Trust
VMO
$614M
| $9.9M | ﹤0.01% |
999,416
-64,554
| -6% | -$626K |
2014 Q4
46 quarters
|
|
3454
Dyne Therapeutics
DYN
$3.49B
| $9.8M | ﹤0.01% |
443,284
+62,723
| +16% | +$1.17M |
2021 Q3
19 quarters
|
|
3455
Westlake Chemical Partners
WLKP
$741M
| $9.8M | ﹤0.01% |
442,165
-15,562
| -3% | -$355K |
2014 Q4
46 quarters
|
|
3456
COPT Defense Properties
CDP
$3.79B
| $9.8M | ﹤0.01% |
270,287
+43,782
| +19% | +$1.42M |
2014 Q4
46 quarters
|
|
3457
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$432M
| $9.8M | ﹤0.01% |
196,066
-7,089
| -3% | -$334K |
2015 Q1
45 quarters
|
|
3458
M/I Homes
MHO
$3.43B
| $9.8M | ﹤0.01% |
61,149
+11,799
| +24% | +$1.58M |
2014 Q4
46 quarters
|
|
3459
Azenta
AZTA
$1.79B
| $9.8M | ﹤0.01% |
385,166
-183,929
| -32% | -$4.12M |
2014 Q4
46 quarters
|
|
3460
ADMA Biologics
ADMA
$2.84B
| $9.8M | ﹤0.01% |
1,173,033
-977,243
| -45% | -$8.91M |
2022 Q3
15 quarters
|
|
3461
DoubleVerify
DV
$2.12B
| $9.8M | ﹤0.01% |
905,436
+63,536
| +8% | +$654K |
2022 Q1
17 quarters
|
|
3462
CALL
Bristol-Myers Squibb
BMY
$127B
| $9.8M | ﹤0.01% |
170,300
-133,000
| -44% | -$7.64M |
2016 Q2
40 quarters
|
|
3463
Prudential
PUK
$31.8B
| $9.8M | ﹤0.01% |
366,008
+298,080
| +439% | +$8.7M |
2014 Q4
46 quarters
|
|
3464
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$5.11B
| $9.8M | ﹤0.01% |
302,844
+293,146
| +3,023% | +$34.9M |
2023 Q4
10 quarters
|
|
3465
Versigent PLC
VGNT
$2.95B
| $9.8M | ﹤0.01% |
233,564
+232,070
| +15,533% | +$9.25M |
2026 Q1
1 quarter
|
|
3466
PUT
Boston Scientific
BSX
$63.8B
| $9.8M | ﹤0.01% |
229,600
-30,100
| -12% | -$1.63M |
2018 Q1
33 quarters
|
|
3467
OceanaGold Corp
OGC
$6.43B
| $9.8M | ﹤0.01% |
+390,716
| New | +$11.7M |
2026 Q2
0 quarters
|
|
3468
CVR Energy
CVI
$4.34B
| $9.8M | ﹤0.01% |
355,747
+2,010
| +0.6% | +$63.8K |
2014 Q4
46 quarters
|
|
3469
Nuveen Multi-Asset Income Fund
NMAI
$458M
| $9.8M | ﹤0.01% |
690,881
+19,527
| +3% | +$268K |
2021 Q4
18 quarters
|
|
3470
STAAR Surgical
STAA
$1.23B
| $9.8M | ﹤0.01% |
341,183
+161,254
| +90% | +$4.48M |
2014 Q4
46 quarters
|
|
3471
Sprott Uranium Miners ETF
URNM
$1.8B
| $9.8M | ﹤0.01% |
185,945
+3,035
| +2% | +$188K |
2021 Q1
21 quarters
|
|
3472
Procept Biorobotics
PRCT
$1.29B
| $9.8M | ﹤0.01% |
432,993
-71,500
| -14% | -$1.79M |
2021 Q3
19 quarters
|
|
3473
iShares MSCI Hong Kong ETF
EWH
$1.31B
| $9.8M | ﹤0.01% |
466,455
+316,853
| +212% | +$7.29M |
2014 Q4
46 quarters
|
|
3474
Mineralys Therapeutics
MLYS
$1.4B
| $9.8M | ﹤0.01% |
361,596
+263,567
| +269% | +$7.23M |
2023 Q2
12 quarters
|
|
3475
CALL
QuantumScape Corp
QS
$2.83B
| $9.7M | ﹤0.01% |
1,288,500
+876,000
| +212% | +$6.57M |
2025 Q3
3 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,282 new, 4,216 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,282 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.